MM
Maria Mastri Scrivens
Director Of Technology Development at Vaccinex
View Maria's Contact Info for Free. Sign Up and Get 50 Free Contacts Per Month.Get Started for Free
Work Experience
Jul 2016 - Present · 8 years and 5 months
Director Of Technology Development
May 2022 - Present · 2 years and 7 months
Team, Leader, Activmab® Technology Development
Sep 2019 - May 2022 · 2 years and 8 months
Team Leader, Antibody Selection
Jul 2016 - Sep 2019 · 3 years and 2 months
Company Details
51-200 Employees
Vaccinex (NASDAQ: VCNX) is a clinical stage biotechnology company pioneering a differentiated approach to treating cancer and progressive neurodegenerative diseases through the inhibition of semaphorin 4D (SEMA4D). The Company’s lead drug candidate, pepinemab, blocks SEMA4D, a potent biological effector that it believes prevents immune infiltration into tumors and triggers damaging inflammation in chronic diseases of the brain. Pepinemab is being evaluated in a Phase 1b/2 study in recurrent or metastatic head and neck cancer and in a Phase 1/2a study in Alzheimer’s Disease, with ongoing exploration of potential Phase 3 development in Huntington’s disease. The Company has also developed a proprietary drug discovery platform, ActivMAb®, that it is leveraging thru strategic collaborations, particularly by exploiting its unique capability to select high value antibodies against important multi-pass membrane receptors.
Year Founded
1997
Social Media
LinkedinFacebookTwitter
Industry
Biotechnology Research
HQ Location
1895 Mt Hope Ave Rochester, New York 14620, US
Keywords
--
Discover More About Cleveland Clinic

Find verified contacts of Maria Mastri Scrivens in seconds from 700M people profiles. Start now!

No Credit Card Needed. By signing up, you understand and agree to Futern's Terms and Policy.